Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 9 Results

  1. 1

    Female condom repackaging cuts cost in Zimbabwe. Lessons learned.

    John Snow [JSI]. DELIVER

    Arlington, Virginia, JSI, DELIVER, 2011 Jul. [3] p. (Lessons Learned)

    By repackaging the female condoms, DTTU teams now spend less time taking inventory, loss of product has been reduced, and the inventory data are much more accurate.
    Add to my documents.
  2. 2

    Breakeven analysis for various human papillomavirus vaccine presentations in Vietnam and Uganda.

    Lorenson K; Garnett A; Kristensen D; Nga N

    Seattle, Washington, PATH, 2010 Aug. [20] p.

    The study highlighted in this project Optimize report uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus (HPV) vaccine presentations.
    Add to my documents.
  3. 3

    An improved passive vaccine carrier.

    Program for Appropriate Technology in Health [PATH]

    Seattle, Washington, PATH, 2012 Apr. [1] p. (Technology Solutions for Global Health)

    Part of the Technology Updates series, this fact sheet describes PATH’s work to address the problem of vaccines freezing during transport by incorporating an inner vaccine box made of phase-change material into vaccine carriers.
    Add to my documents.
  4. 4

    Developing a vision for immunization supply systems in 2020. Landscape analysis summaries.

    Program for Appropriate Technology in Health [PATH]; World Health Organization [WHO]

    [Seattle, Washington], PATH, 2011 Jun. [47] p.

    Facilitated by project Optimize and conducted by a multidisciplinary group of partners, these landscape analyses highlight ongoing work related to five priority areas that comprise the vision for immunization supply systems in 2020. The analyses also highlight critical gaps that need to be addressed to achieve the vision. The five priority areas are vaccine and related products, supply system design, environmental impact, information systems, and human resources.
    Add to my documents.
  5. 5
    Peer Reviewed

    New approaches to immunization logistics.

    Zipursky S; Kristensen D; Zaffran M

    Global Health. 2010 Fall; [4] p.

    Improving the health outcomes for the world’s children is a priority in global health. The recent launch of the Decade of Vaccines by the Bill & Melinda Gates Foundation, strongly supported by the WHO Director General, Margaret Chan, in her recent speech to the World Health Assembly, has renewed the world’s attention and commitment to combating vaccine-preventable diseases. It is good news that many countries now have the chance to add new vaccines to their programs, but we need to ensure that the systems tasked with delivering them are able to cope. Innovative solutions exist -- and they have been shown to significantly improve vaccine performance and delivery. Yet, there is work to be done. Without fully adequate or reliable vaccine delivery systems, the backbone of immunization, lifesaving interventions will not reach the very people who need them most. (Excerpt)
    Add to my documents.
  6. 6

    Public health product catalog 2010.

    United States. Agency for International Development [USAID]; John Snow [JSI]. DELIVER

    Arlington, Virginia, JSI, DELIVER, 2009. [14] p. (USAID Contract No. GPO-I-01-06-00007-00)

    USAID's Public Health Product Catalog 2010 is a catalog of condoms and contraceptives provided by USAID.
    Add to my documents.
  7. 7

    Oral rehydration salts. Production of the new ORS.

    World Health Organization [WHO]. Department of Child and Adolescent Health and Development; UNICEF. Supply Division

    Geneva, Switzerland, WHO, 2006. [122] p. (WHO/FCH/CAH/06.1)

    This document is updating an earlier document (WHO/CDD/SER/85.8), and provides information on the manufacture of the new ORS that, since 2003, is recommended by WHO and UNICEF. It has been prepared to assist national authorities in establishing the local manufacture of a product of pharmaceutical quality, in order that they may become self-reliant in meeting the needs of their national diarrhoeal diseases control activities. It is emphasized that the methods recommended in the document are meant to serve as guidelines, and that they need to be adapted to meet local requirements and conditions, provided they follow the principles of Good Manufacturing Practices for pharmaceutical products (WHO Technical Report Series, No 908, 2003) that can be found in the annexes of this document. Specific information on "Quality Management", "Personnel", "Validation" and "Qualification" can be found in this annex. (excerpt)
    Add to my documents.
  8. 8

    Contraceptive fact sheets: a tool for logistics advisors.

    John Snow [JSI]. Family Planning Logistics Management Project

    Arlington, Virginia, JSI, 1997. [16] p.

    This document includes fact sheets on the logistics associated with supplying the major modern contraceptive methods: condoms, oral contraceptives, IUDs, injectables, implants, and spermicidal/vaginal barrier methods. Described, for each method, are visual indicators of potential quality problems, recommended storage conditions, special considerations, donors/manufacturers/brands, shelf life, primary/secondary packaging presentation, units per shipping carton, and dimensions and weight of cartons. Also cited are general and method-specific references for additional information.
    Add to my documents.
  9. 9

    Ozone in smog deteriorates latex condoms.

    OUTLOOK. 1989 Mar; 7(1):9-10.

    Laboratory tests indicate that nonlubricated, unpackaged, latex condoms suffer rapid deterioration from direct exposure to ozone levels common in urban smog conditions. The results clearly indicate a need for careful handling of condoms during transport and storage to protect them from accelerated deterioration which can lead to breakage during use. The study was conducted with commercially available, unlubricated condoms. Treatment and control condoms came from the same packages. In the treatment group, 5 condoms were unwrapped and unrolled loosely over glass test tubes, place in a chamber and exposed to 0.27-0.28ppm of ozone (the level common in urban smog). The control group condoms were unwrapped, but left rolled up and were not exposed to zone. The treated condoms showed increased surface damage after 6-48 hours of zone damage. Damage was determined by examination of a cut edge under an electron microscope. Air burst tests revealed that the exposed condoms burst at 44% of the pressure of the untreated condoms. Condoms that are sealed in their packaging will be protected from ozone exposure; however, condoms should still be handled in a manner that will reduce their likelihood of exposure to ozone during storage and transportation.
    Add to my documents.